233 related articles for article (PubMed ID: 23892208)
1. A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease.
Naert G; Rivest S
J Mol Cell Biol; 2013 Oct; 5(5):284-93. PubMed ID: 23892208
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
El Khoury J; Luster AD
Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
[TBL] [Abstract][Full Text] [Related]
3. Monocytes and Alzheimer's disease.
Feng Y; Li L; Sun XH
Neurosci Bull; 2011 Apr; 27(2):115-22. PubMed ID: 21441973
[TBL] [Abstract][Full Text] [Related]
4. The role and therapeutic potential of monocytic cells in Alzheimer's disease.
Malm T; Koistinaho M; Muona A; Magga J; Koistinaho J
Glia; 2010 Jun; 58(8):889-900. PubMed ID: 20155817
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
[TBL] [Abstract][Full Text] [Related]
6. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease.
El Khoury J; Toft M; Hickman SE; Means TK; Terada K; Geula C; Luster AD
Nat Med; 2007 Apr; 13(4):432-8. PubMed ID: 17351623
[TBL] [Abstract][Full Text] [Related]
7. Decoding the role of the CCL2/CCR2 axis in Alzheimer's disease and innovating therapeutic approaches: Keeping All options open.
Arfaei R; Mikaeili N; Daj F; Boroumand A; Kheyri A; Yaraghi P; Shirzad Z; Keshavarz M; Hassanshahi G; Jafarzadeh A; Shahrokhi VM; Khorramdelazad H
Int Immunopharmacol; 2024 Jun; 135():112328. PubMed ID: 38796962
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease.
Hickman SE; El Khoury J
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):168-73. PubMed ID: 20205643
[TBL] [Abstract][Full Text] [Related]
9. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
Lee JK; Schuchman EH; Jin HK; Bae JS
Stem Cells; 2012 Jul; 30(7):1544-55. PubMed ID: 22570192
[TBL] [Abstract][Full Text] [Related]
10. Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.
Zuroff L; Daley D; Black KL; Koronyo-Hamaoui M
Cell Mol Life Sci; 2017 Jun; 74(12):2167-2201. PubMed ID: 28197669
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.
Lee JK; Jin HK; Bae JS
Neurosci Lett; 2009 Jan; 450(2):136-41. PubMed ID: 19084047
[TBL] [Abstract][Full Text] [Related]
12. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
[TBL] [Abstract][Full Text] [Related]
13. Microglial activation in Alzheimer's disease.
Schlachetzki JC; Hüll M
Curr Alzheimer Res; 2009 Dec; 6(6):554-63. PubMed ID: 19747160
[TBL] [Abstract][Full Text] [Related]
14. CD11a expression distinguishes infiltrating myeloid cells from plaque-associated microglia in Alzheimer's disease.
Shukla AK; McIntyre LL; Marsh SE; Schneider CA; Hoover EM; Walsh CM; Lodoen MB; Blurton-Jones M; Inlay MA
Glia; 2019 May; 67(5):844-856. PubMed ID: 30588668
[TBL] [Abstract][Full Text] [Related]
15. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease.
Mildner A; Schlevogt B; Kierdorf K; Böttcher C; Erny D; Kummer MP; Quinn M; Brück W; Bechmann I; Heneka MT; Priller J; Prinz M
J Neurosci; 2011 Aug; 31(31):11159-71. PubMed ID: 21813677
[TBL] [Abstract][Full Text] [Related]
16. Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease.
Malm TM; Magga J; Kuh GF; Vatanen T; Koistinaho M; Koistinaho J
Glia; 2008 Dec; 56(16):1767-79. PubMed ID: 18649403
[TBL] [Abstract][Full Text] [Related]
17. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
Walker DG; Lue LF
J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
[TBL] [Abstract][Full Text] [Related]
18. Cellular players that shape evolving pathology and neurodegeneration following traumatic brain injury.
Puntambekar SS; Saber M; Lamb BT; Kokiko-Cochran ON
Brain Behav Immun; 2018 Jul; 71():9-17. PubMed ID: 29601944
[TBL] [Abstract][Full Text] [Related]
19. CXCL1 contributes to β-amyloid-induced transendothelial migration of monocytes in Alzheimer's disease.
Zhang K; Tian L; Liu L; Feng Y; Dong YB; Li B; Shang DS; Fang WG; Cao YP; Chen YH
PLoS One; 2013; 8(8):e72744. PubMed ID: 23967336
[TBL] [Abstract][Full Text] [Related]
20. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
